2023 White Paper on Recent Issues in Bioanalysis: EU IVDR 2017/746 Implementation/Impact, IVD/CDx/CLIA Approved Assays, High Dimensional Cytometry, Multiplexing Technologies, LBA Tissue Analysis, Vaccine Study Endpoints, Cell-Based Assays for Biomarkers, Cell Therapy and Vaccines (<underline>PART 2</underline> - Recommendations on Development & Validation of Biomarkers, IVD, CDx, Cell-Based, Flow Cytometry, Ligand-Binding and Enzyme Assays; Advanced Critical Reagents Strategies)

被引:0
|
作者
Kholmanskikh, Olga [14 ]
Wang, Yow-Ming [7 ]
Hersey, Sarah [2 ]
Wadhwa, Meenu [4 ]
Block, Katherine [1 ]
Bandukwala, Abbas [7 ]
Szapacs, Matthew [3 ]
Weiner, Russell [5 ]
Awwad, Khader [6 ]
Dessy, Francis [8 ,9 ]
Downing, Sean [5 ]
Du, Xiulian [7 ]
Garofolo, Fabio [10 ]
Harris, Shannon [11 ]
Hou, Victor [12 ]
Jones, Jennifer [2 ]
Kar, Sumit [13 ]
Kinhikar, Arvind [15 ]
Li, Ming [16 ]
Mathews, Joel [17 ]
Meissen, John [18 ]
Sumner, Giane Oliveira [19 ]
Pan, Luying [5 ]
Sanderink, Gerard [20 ]
Scully, Ingrid [21 ]
Stanta, Johannes [22 ]
Tanaka, Yoichi [23 ]
Vauleon, Stephanie [24 ]
Wagner, Leslie [7 ]
Wang, Kai [25 ]
Zhu, Liang [12 ]
Eck, Steven [27 ]
Lin, Yi-Dong [5 ]
Azadeh, Mitra [26 ]
Decman, Vilma [25 ]
Diebold, Sandra [4 ]
Goihberg, Polina [28 ]
Alcaide, Enrique Gomez [24 ]
Gonneau, Christele [29 ]
Hedrick, Michael Nathan [2 ]
Hopkins, Gregory [30 ]
Loschko, Jakob [21 ]
Mccausland, Megan [31 ]
Mendez, Luis [32 ]
Sehra, Sarita [33 ]
Stevens, Erin [34 ]
Sun, Yongliang Steve [2 ]
Tangri, Shabnam [35 ]
Trampont, Paul C. [12 ]
Cludts, Isabelle [4 ]
机构
[1] Genentech Inc, San Francisco, CA USA
[2] Bristol Myers Squibb, Lawrenceville, NJ USA
[3] Abbvie, Philadelphia, PA USA
[4] UK MHRA, London, England
[5] Takeda, Cambridge, MA USA
[6] Abbvie, Ludwigshafen, Germany
[7] US FDA, Silver Spring, MD USA
[8] GlaxoSmithKline, Rixensart, Belgium
[9] Takeda, Cambridge, MA USA
[10] BRI Frontage, Vancouver, BC, Canada
[11] HilleVax, Cambridge, MA USA
[12] Moderna, Cambridge, MA USA
[13] WRIB, Toronto, ON, Canada
[14] Belgium FAMHP, Brussels, Belgium
[15] Novartis, Cambridge, MA USA
[16] Stoke, Cambridge, MA USA
[17] Ionis, Carlsbad, CA USA
[18] AstraZeneca, San Francisco, CA USA
[19] Regeneron, Tarrytown, NY USA
[20] Sanofi Pasteur, Swiftwater, PA USA
[21] Pfizer, Pearl River, NY USA
[22] Celerion, Stevenage, England
[23] Japan MHLW, Tokyo, Japan
[24] F Hoffmann La Roche Ltd, Basel, Switzerland
[25] GlaxoSmithKline, Collegeville, PA USA
[26] Ultragenyx, Cambridge, MA USA
[27] AstraZeneca, Gaithersburg, MD USA
[28] Pfizer, Andover, MA USA
[29] Labcorp, Meyrin, Switzerland
[30] 2seventy Bio, Cambridge, MA USA
[31] Q2 Solut, Atlanta, GA USA
[32] Merck, Kenilworth, NJ USA
[33] Incyte, Wilmington, DE USA
[34] Pfizer, Groton, CT USA
[35] Navigate, San Diego, CA USA
[36] Alexion, New Haven, CT USA
[37] Spark Therapeut, Plainsboro, NJ USA
[38] Pfizer, Kirkland, PQ, Canada
[39] Fresenius Kabi, Bad Homburg, Germany
[40] Sanofi, Ghent, Belgium
[41] Frontage, Exton, PA USA
[42] Alnylam, Cambridge, MA USA
关键词
bioanalysis; biomarkers; cell therapy; gene therapy; immunogenicity; vaccine; WRIB; PART 2-HYBRID LBA/LCMS; EXTRACELLULAR VESICLES; REGULATED BIOANALYSIS; SMALL MOLECULES; FOCUS; IMMUNOGENICITY; CALIBRATION; INPUT; 3-LBA; GENE;
D O I
10.1080/17576180.2024.2340961
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The 17th Workshop on Recent Issues in Bioanalysis (17th WRIB) took place in Orlando, FL, USA on 19-23 June 2023. Over 1000 professionals representing pharma/biotech companies, CROs, and multiple regulatory agencies convened to actively discuss the most current topics of interest in bioanalysis. The 17th WRIB included 3 Main Workshops and 7 Specialized Workshops that together spanned 1 week to allow an exhaustive and thorough coverage of all major issues in bioanalysis of biomarkers, immunogenicity, gene therapy, cell therapy and vaccines. Moreover, in-depth workshops on "EU IVDR 2017/746 Implementation and impact for the Global Biomarker Community: How to Comply with these NEW Regulations" and on "US FDA/OSIS Remote Regulatory Assessments (RRAs)" were the special features of the 17th edition. As in previous years, WRIB continued to gather a wide diversity of international, industry opinion leaders and regulatory authority experts working on both small and large molecules as well as gene, cell therapies and vaccines to facilitate sharing and discussions focused on improving quality, increasing regulatory compliance, and achieving scientific excellence on bioanalytical issues. This 2023 White Paper encompasses recommendations emerging from the extensive discussions held during the workshop and is aimed to provide the bioanalytical community with key information and practical solutions on topics and issues addressed, in an effort to enable advances in scientific excellence, improved quality and better regulatory compliance. Due to its length, the 2023 edition of this comprehensive White Paper has been divided into three parts for editorial reasons. This publication (Part 2) covers the recommendations on Biomarkers, IVD/CDx, LBA and Cell-Based Assays. Part 1A (Mass Spectrometry Assays and Regulated Bioanalysis/BMV), P1B (Regulatory Inputs) and Part 3 (Gene Therapy, Cell therapy, Vaccines and Biotherapeutics Immunogenicity) are published in volume 16 of Bioanalysis, issues 9 and 7 (2024), respectively.
引用
收藏
页码:179 / 220
页数:42
相关论文
共 1 条
  • [1] 2022 White Paper on Recent Issues in Bioanalysis: Enzyme Assay Validation, BAV for Primary End Points, Vaccine Functional Assays, Cytometry in Tissue, LBA in Rare Matrices, Complex NAb Assays, Spectral Cytometry, Endogenous Analytes, Extracellular Vesicles Part 2-Recommendations on Biomarkers/CDx, Flow Cytometry, Ligand-Binding Assays Development & Validation; Emerging Technologies; Critical Reagents Deep Characterization
    Sumner, Giane
    Keller, Steve
    Huleatt, James
    Staack, Roland F.
    Wagner, Leslie
    Azadeh, Mitra
    Bandukwala, Abbas
    Cao, Liching
    Du, Xiulian
    Salinas, Gabriela Franco
    Garofolo, Fabio
    Harris, Shannon
    Hopper, Shirley
    Irwin, Chad
    Ji, Qin
    Joseph, Julie
    King, Lindsay
    Kinhikar, Arvind
    Lu, Yang
    Luo, Rosa
    Mabrouk, Omar
    Malvaux, Ludovic
    Marshall, Jean-Claude
    McGuire, Kristina
    Mikol, Vincent
    Neely, Robert
    Qiu, Xiazi
    Saito, Yoshiro
    Salaun, Bruno
    Scully, Ingrid
    Smeraglia, John
    Solstad, Therese
    Stoop, Jeroen
    Tang, Huaping
    Teixeira, Priscila
    Wang, Yixin
    Wright, Mike
    Mendez, Luis
    Beaver, Chris
    Eacret, Jacqueline
    Au-Yeung, Amelia
    Decman, Vilma
    Dessy, Francis
    Eck, Steven
    Goihberg, Polina
    Alcaide, Enrique Gomez
    Gonneau, Christele
    Grugan, Katharine
    Hedrick, Michael Nathan
    Kar, Sumit
    [J]. BIOANALYSIS, 2023, 15 (15) : 861 - 903